neutrophil peptide 5

was SY to defensins until 2001; this is human: do not confuse with peptide NP-5 (rabbit)

Also Known As:

HNP-5; HP-5 peptide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Pore Forming Cytotoxic Proteins
      - Antimicrobial Cationic Peptides: 414
        Defensins: 1422
        alpha-Defensins: 313
        neutrophil peptide 5: 1
- Peptides: 82426
  - Antimicrobial Peptides: 3727
    - Antimicrobial Cationic Peptides: 414
      - Defensins: 1422
        alpha-Defensins: 313
        neutrophil peptide 5: 1
  - Antimicrobial Cationic Peptides: 414
    - Defensins: 1422
      - alpha-Defensins: 313
        neutrophil peptide 5: 1

Experts

1.	Bundy, Jonathan L: 1 article (01/2009)
2.	Gardner, Michael S: 1 article (01/2009)
3.	Rowland, Megan D: 1 article (01/2009)
4.	Siu, Amy Y: 1 article (01/2009)
5.	Stephenson, James L: 1 article (01/2009)
6.	Wagener, Diane K: 1 article (01/2009)

Related Diseases

1.	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
2.	Neoplasms (Cancer) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
3.	Infections 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
4.	Cystic Fibrosis (Mucoviscidosis) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "
5.	Crohn Disease (Crohn's Disease) 01/15/2009 - "In addition, these peptides are involved in CD8+ T cell response to HIV-1, increased pulmonary infection risk among cystic fibrosis patients, upregulated levels of HNP-5 for patients with ulcerative colitis and Crohn's disease, and monitoring HNP-3 levels as a tumor classification scheme for cutaneous T cell lymphomas, and have promise in the pharmaceutical field as a new class of antibiotics. "

Related Drugs and Biologics

1.	Peptides (Polypeptides)
2.	Anti-Bacterial Agents (Antibiotics)
3.	human neutrophil peptide 3